Insider · CIK 0001181186

YARNO WENDY L

Reports to the SEC for 12 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001181186

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+302 sh	—	—	16,956
2026-09-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−302 sh	—	—	907
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,837 sh	—	—	3,837
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,417 sh	—	—	2,417
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,209 sh	—	—	1,209
2026-06-16	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-06-12	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,954 sh	—	—	16,654
2026-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,954 sh	—	—	0
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+41.8K sh	—	—	41,800
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+34.2K sh	—	—	34,200
2025-06-24	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-06-13	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	13,700
2025-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2025-06-13	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+67.5K sh	—	—	67,546
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,540 sh	—	—	4,540
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,954 sh	—	—	2,954
2025-05-21	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,167 sh	—	—	10,512
2025-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,167 sh	—	—	0
2024-06-24	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	10,350
2024-06-24	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2024-06-11	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+49.3K sh	—	—	49,303
2024-05-31	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.2K sh	—	—	16,200
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+2,917 sh	—	—	2,917
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,167 sh	—	—	2,167
2024-05-15	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,166 sh	—	—	8,345
2024-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,166 sh	—	—	0
2024-03-01	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+25K sh	—	—	25,000
2023-12-02	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	7,000
2023-12-02	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2023-06-16	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	2,000
2023-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2023-06-07	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.2K sh	—	—	16,200
2023-06-06	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+13K sh	—	—	12,988
2023-05-16	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+19K sh	—	—	74,153
2023-05-16	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−19K sh	—	—	0
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+26K sh	—	—	26,000
2023-04-18	IOVAIOVANCE BIOTHERAPEUTICS, INC. · Deferred Restricted Stock UnitA Award	Director	AAward	+74.8K sh	—	—	74,823
2022-12-02	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+5,000 sh	—	—	5,000
2022-10-05	Global Blood Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−11.4K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−3,600 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,247 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,600 sh	—	—	0

Recent filings

Accepted (ET)
Sep 174
YARNO WENDY L0001181186-26-000008
SEC(opens sec.gov)
Jun 294
YARNO WENDY L0001181186-26-000006
SEC(opens sec.gov)
Jun 184
YARNO WENDY L0001610717-26-000265
SEC(opens sec.gov)
Jun 164
YARNO WENDY L0001181186-26-000004
SEC(opens sec.gov)
May 214
YARNO WENDY L0001181186-26-000002
SEC(opens sec.gov)
Jun 264
YARNO WENDY L0001610717-25-000265
SEC(opens sec.gov)
Jun 174
YARNO WENDY L0001104659-25-060245
SEC(opens sec.gov)
Jun 164
YARNO WENDY L0001819790-25-000091
SEC(opens sec.gov)
May 214
YARNO WENDY L0001055726-25-000036
SEC(opens sec.gov)
Jun 254
YARNO WENDY L0001819790-24-000097
SEC(opens sec.gov)

Companies

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618